Trial Profile
A multi-center, double-blind, randomized, placebo-controlled, parallel design study to evaluate the efficacy and safety of intravenous tedisamil sesquifumarate in the rapid conversion to normal sinus rhythm in female subjects with recent onset atrial fibrillation.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Jan 2015
Price :
$35
*
At a glance
- Drugs Tedisamil (Primary)
- Indications Atrial fibrillation; Atrial flutter
- Focus Registrational; Therapeutic Use
- 20 Apr 2010 Additional trial locations identified as reported by ClinicalTrials.gov.
- 29 Oct 2005 New trial record.